Label: AMELUZ- aminolevulinic acid hydrochloride gel

  • NDC Code(s): 70621-101-01, 70621-101-03, 70621-101-10, 70621-101-20, view more
  • Packager: Biofrontera Inc.
  • Category: HUMAN PRESCRIPTION DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: New Drug Application

Drug Label Information

Updated December 16, 2024

If you are a consumer or patient please visit this version.

  • HIGHLIGHTS OF PRESCRIBING INFORMATION
    These highlights do not include all the information needed to use AMELUZ safely and effectively. See full prescribing information for AMELUZ. AMELUZ® (aminolevulinic acid hydrochloride) topical ...
  • Table of Contents
    Table of Contents
  • 1. INDICATIONS AND USAGE
    AMELUZ, in combination with photodynamic therapy (PDT) using BF-RhodoLED® or RhodoLED® XL lamp, a narrowband, red light illumination source, is indicated for lesion-directed and field-directed ...
  • 2. DOSAGE AND ADMINISTRATION
    2.1 Important Administration Information - AMELUZ, in conjunction with lesion preparation, is only to be administered by a health care provider. AMELUZ is for topical use only. Not for ...
  • 3. DOSAGE FORMS AND STRENGTHS
    Topical gel: 10% aminolevulinic acid hydrochloride as a white-to-yellowish gel in 2-gram tubes.
  • 4. CONTRAINDICATIONS
    AMELUZ is contraindicated in patients with: Known hypersensitivity to porphyrins. Known hypersensitivity to any of the components of AMELUZ, which includes soybean phosphatidylcholine [see ...
  • 5. WARNINGS AND PRECAUTIONS
    5.1 Hypersensitivity - Several cases of hypersensitivity were reported during postmarketing use of AMELUZ prior to PDT illumination [see Adverse Reactions (6.2)]. If allergic reactions occur ...
  • 6. ADVERSE REACTIONS
    The following adverse reactions are discussed in greater detail in other sections of the labeling: ​Hypersensitivity [see Warnings and Precautions (5.1)]. Transient Amnestic Episodes [see ...
  • 7. DRUG INTERACTIONS
    There have been no formal studies of the interaction of AMELUZ with other drugs. It is possible that concomitant use of other known photosensitizing agents such as St. John’s wort, griseofulvin ...
  • 8. USE IN SPECIFIC POPULATIONS
    8.1 Pregnancy - Risk Summary - There are no available data on AMELUZ use in pregnant women to inform a drug associated risk. Animal reproduction studies were not conducted with aminolevulinic ...
  • 11. DESCRIPTION
    AMELUZ (aminolevulinic acid hydrochloride) topical gel, 10% is a non-sterile white-to-yellowish gel. The gel formulation contains a nanoemulsion. Aminolevulinic acid, a porphyrin precursor, is a ...
  • 12. CLINICAL PHARMACOLOGY
    12.1 Mechanism of Action - Photoactivation following topical application of AMELUZ occurs when aminolevulinic acid (prodrug) is metabolized to protoporphyrin IX (PpIX), a photoactive compound ...
  • 13. NONCLINICAL TOXICOLOGY
    13.1 Carcinogenesis, Mutagenesis, Impairment of Fertility - Long-term studies to evaluate the carcinogenic potential of AMELUZ or aminolevulinic acid have not been performed. Aminolevulinic acid ...
  • 14. CLINICAL STUDIES
    The efficacy and safety of AMELUZ in combination with PDT using a narrow spectrum (red light lamp) source were evaluated in three randomized, multicenter trials (Trials 1, 2, and 3). Trials 2 and ...
  • 16. HOW SUPPLIED/STORAGE AND HANDLING
    AMELUZ (aminolevulinic acid hydrochloride) topical gel, 10% is a white-to-yellowish gel. The drug product is supplied in an aluminum tube with a white, high density polyethylene (HDPE) screw cap ...
  • 17. PATIENT COUNSELING INFORMATION
    Inform patients of the following: Hypersensitivity - Hypersensitivity has been reported with use of AMELUZ. Inform patients and their caregivers that AMELUZ may cause hypersensitivity ...
  • SPL UNCLASSIFIED SECTION
    AMELUZ, BF-RhodoLED and RhodoLED are registered trade marks of Biofrontera Pharma GmbH.
  • SPL UNCLASSIFIED SECTION
    PATENT INFO - Patent 11,540,981
  • SPL UNCLASSIFIED SECTION
    Distributed by: Biofrontera Inc. 120 Presidential Way - Suite 330 - Woburn, MA 01801 - USA
  • INSTRUCTION FOR USE
    User Manual - Manufacturer: Biofrontera Pharma GmbH - Distributor: Biofrontera Inc. Foreword - Thank you for choosing the BF-RhodoLED® LED lamp for your photodynamic therapy ...
  • INSTRUCTION FOR USE
    User Manual - Manufacturer: Biofrontera Pharma GmbH - Distributor: Biofrontera Inc. Foreword - Thank you for choosing the RhodoLED® XL LED lamp for your photodynamic therapy. RhodoLED ...
  • PRINCIPAL DISPLAY PANEL – OUTER PACKAGING
    Outer Packaging, single Carton - NDC 70621-101-10 - Ameluz® Rx Only - (aminolevulinic acid HCl) topical gel, 10% Use contents within 3 months after opening. Discard after: __/ __/ __. Store ...
  • INGREDIENTS AND APPEARANCE
    Product Information